Table 2.
28-day cumulative incidence (per 100,000 persons) of autoimmune conditions among vaccine recipients and non-vaccinated individuals.
| Body system | Disease | First dose |
Second dose |
||||
|---|---|---|---|---|---|---|---|
| None | BNT162b2 | CoronaVac | None | BNT162b2 | CoronaVac | ||
| Cardiovascular system | Kawasaki disease | 0.080 | 0.00 | 0.00 | 0.00 | 0.29 | 0.00 |
| Single organ cutaneous vasculitis | 0.066 | 0.13 | 0.00 | 0.12 | 0.00 | 0.00 | |
| Endocrine system | Subacute thyroiditis | 0.090 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Hematological system | Anti-phospholipid antibody syndrome | 0.19 | 0.27 | 0.46 | 0.32 | 0.00 | 0.00 |
| Thrombocytopenia | 0.64 | 0.39 | 0.11 | 0.57 | 1.11 | 0.00 | |
| Multisystem | Sjogren's syndrome | 0.13 | 0.14 | 0.11 | 0.12 | 0.00 | 0.00 |
| Systemic lupus erythematosus | 1.21 | 0.15 | 0.22 | 1.21 | 0.20 | 0.00 | |
| Musculoskeletal system | Acute aseptic arthritis | 2.07 | 0.61 | 1.71 | 2.21 | 1.85 | 2.80 |
| Reactive arthritis | 8.49 | 4.12 | 5.46 | 8.56 | 7.24 | 8.53 | |
| Rheumatoid arthritis | 1.60 | 0.34 | 0.57 | 1.69 | 0.36 | 0.77 | |
| Psoriatic arthritis | 0.38 | 0.26 | 0.39 | 0.37 | 0.20 | 0.82 | |
| Spondyloarthritis | 0.40 | 0.14 | 0.12 | 0.42 | 0.00 | 0.00 | |
| Nervous system | Acute disseminated encephalomyelitis | 0.00 | 0.00 | 0.00 | 0.071 | 0.55 | 0.00 |
| Guillain-Barré syndrome | 0.062 | 0.14 | 0.00 | 0.10 | 0.00 | 0.00 | |
| Narcolepsy and related disorders | 7.62 | 8.35 | 4.17 | 7.55 | 6.86 | 7.74 | |
| Transverse myelitis | 0.00 | 0.00 | 0.00 | 0.07 | 0.55 | 0.00 | |
| All-cause death | Death | 60.47 | 3.29 | 4.54 | 63.18 | 6.83 | 3.98 |